Dataset from An Open Label, Phase I Trial to Investigate the Pharmacokinetics and Pharmacodynamics of Linagliptin (BI 1356) 5 mg After Single and Multiple Oral Administration in Patients With Type 2 Diabetes Mellitus of African American Origin for 7 Days

NIAID Data Ecosystem2026-05-02 收录

2型糖尿病药物药代动力学

非裔美国人药效学

数据链接：

https://doi.org/10.25934/00003575 数据链接链接失效反馈

官方服务：

资源简介：

The objective of this trial is to investigate the pharmacokinetics and pharmacodynamics of linagliptin (BI 1356) 5 mg administered orally in patients with Type 2 diabetes mellitus of African American origin.

创建时间：

2024-11-26

Dataset from An Open Label, Phase I Trial to Investigate the Pharmacokinetics and Pharmacodynamics of Linagliptin (BI 1356) 5 mg After Single and Multiple Oral Administration in Patients With Type 2 Diabetes Mellitus of African American Origin for 7 Days

资源简介：

相关数据集